Tag: Mentice AB

Mentice receives order of total SEK 5.9 million from Baylis Medical Company

STOCKHOLM, June 30, 2021 /PRNewswire/ — Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on interventional procedures, has entered into an agreement with Baylis Medical Company (“Baylis”) to provide simulation solutions. Based on this order, Mentice will support Baylis’ product portfolio for transseptal puncture procedures with Mentice systems to be delivered in […]

Mentice publishes the company’s year-end report for the period January-December 2020

STOCKHOLM, Feb. 4, 2021 /PRNewswire/ — Strong order intake and substantial improvement of the company’s order book as well as operating cash flowFourth quarter (October-December 2020) Order intake amounted to 73.1 (54.7) MSEK. Net sales amounted to 45.9 (60.2) MSEK. Operating income for the period before depreciations (EBITDA) totalled 4.3 (11.8) MSEK. Net income for the period amounted […]

Mentice to enhance its organization with several new key positions

STOCKHOLM, Jan. 13, 2021 /PRNewswire/ — Mentice AB (publ), a leading supplier of high-tech solutions for simulation in the medical sector, with focus on endovascular procedures, has announced changes to its organization. Several new key positions have been created, aimed at improving Mentice’s regional presence in the market. Effective January 1st, Mentice has adopted a regional structure for its go-to-market […]

Issuance of new shares in Mentice AB (publ) has been registered with the Swedish Companies Registration Office

STOCKHOLM, Dec. 4, 2020 /PRNewswire/ — Regarding the acquisition of the assets from Vascular Simulations Inc 571,974 shares have been issued at a subscription price of SEK 86.16 and regarding the acquisition of the assets from EQIP Inc, 9,469 shares have been issued at a subscription price of SEK 84.28. The total number of shares in Mentice AB after registration […]

Mentice to Acquire Vascular Simulations

– Combined portfolio will enhance Mentice’s endovascular simulation offerings with world class replication solutions – Acquisition to expand Mentice’s global customer base and offer a strong entry into previously untapped market segments STOCKHOLM, Oct. 1, 2020 /PRNewswire/ — Mentice AB (STO: MNTC) today signed a definitive agreement to acquire the New York-based medical technology company Vascular Simulations (VSI), […]

Mentice Expands its Coronary Product Portfolio With an Advanced Software Solution for Coronary Interventions

Coronary Advanced to Help Fellows and Attending Interventional Cardiologists to Perfect Skills in Complex Scenarios STOCKHOLM, May 21, 2020 /PRNewswire/ — Mentice AB (STO: MNTC), a world leader in high-fidelity endovascular simulation introduces Coronary Advanced for select VIST® platforms. Following the introduction of Coronary Essentials and Coronary Intermediate, Coronary Advanced is the most sophisticated solution, specifically designed for […]